WallStreetZenWallStreetZen

NASDAQ: EHTH
Ehealth Inc Stock Forecast, Predictions & Price Target

Analyst price target for EHTH

Based on 2 analysts offering 12 month price targets for Ehealth Inc.
Min Forecast
$7.00+61.29%
Avg Forecast
$10.00+130.41%
Max Forecast
$13.00+199.54%

Should I buy or sell EHTH stock?

Based on 2 analysts offering ratings for Ehealth Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EHTH stock forecasts and price targets.

EHTH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-11
lockedlocked$00.00+00.00%2024-01-18

1 of 1

Forecast return on equity

Is EHTH forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
20.17%

Forecast return on assets

Is EHTH forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

EHTH revenue forecast

What is EHTH's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$462.1M+2.03%
Avg 2 year Forecast
$496.4M+9.62%
Avg 3 year Forecast
$540.7M+19.39%
EHTH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EHTH revenue growth forecast

How is EHTH forecast to perform vs Insurance Brokers companies and vs the US market?
Company
5%
Industry
7.91%
Market
9.43%
EHTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EHTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EHTH vs Insurance Stocks

TickerPricePrice TargetUp/downsideConsensus
EHTH$4.34$10.00+130.41%Hold
FANH$3.51N/AN/A
CCG$2.37N/AN/A
HUIZ$0.61N/AN/A
GOCO$9.91$13.00+31.18%Hold

Ehealth Stock Forecast FAQ

Is Ehealth Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: EHTH) stock is to Hold EHTH stock.

Out of 2 analysts, 0 (0%) are recommending EHTH as a Strong Buy, 0 (0%) are recommending EHTH as a Buy, 2 (100%) are recommending EHTH as a Hold, 0 (0%) are recommending EHTH as a Sell, and 0 (0%) are recommending EHTH as a Strong Sell.

If you're new to stock investing, here's how to buy Ehealth stock.

What is EHTH's revenue growth forecast for 2024-2026?

(NASDAQ: EHTH) Ehealth's forecast annual revenue growth rate of 5% is not forecast to beat the US Insurance Brokers industry's average forecast revenue growth rate of 7.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.43%.

Ehealth's revenue in 2024 is $452,871,000.On average, 2 Wall Street analysts forecast EHTH's revenue for 2024 to be $13,371,877,300, with the lowest EHTH revenue forecast at $13,261,621,581, and the highest EHTH revenue forecast at $13,482,161,958. On average, 2 Wall Street analysts forecast EHTH's revenue for 2025 to be $14,366,001,900, with the lowest EHTH revenue forecast at $14,107,638,892, and the highest EHTH revenue forecast at $14,624,364,908.

In 2026, EHTH is forecast to generate $15,646,299,415 in revenue, with the lowest revenue forecast at $15,646,299,415 and the highest revenue forecast at $15,646,299,415.

What is EHTH's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: EHTH) forecast ROA is N/A, which is lower than the forecast US Insurance Brokers industry average of N/A.

What is EHTH's Price Target?

According to 2 Wall Street analysts that have issued a 1 year EHTH price target, the average EHTH price target is $10.00, with the highest EHTH stock price forecast at $13.00 and the lowest EHTH stock price forecast at $7.00.

On average, Wall Street analysts predict that Ehealth's share price could reach $10.00 by Mar 11, 2025. The average Ehealth stock price prediction forecasts a potential upside of 130.41% from the current EHTH share price of $4.34.

What is EHTH's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: EHTH) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.